Blood coagulation and fibrinolytic enzyme studies during cyclic and continuous application of progestational agents.
D000328:Adult; D001777:Blood Coagulation / Q000187:drug effects*; D001779:Blood Coagulation Factors / Q000187:drug effects*; D003276:Contraceptives, Oral / Q000494:pharmacology*; D004715:Endometriosis / Q000188:drug therapy*; D004997:Ethinyl Estradiol / Q000494:pharmacology*; D005260:Female; D005341:Fibrinolysin; D006801:Humans; D008525:Medroxyprogesterone / Q000494:pharmacology*; D008656:Mestranol / Q000494:pharmacology*; D009641:Norethynodrel / Q000494:pharmacology*; D010958:Plasminogen; D011372:Progestins / Q000627:therapeutic use*
D001779:Blood Coagulation Factors; D003276:Contraceptives, Oral; D011372:Progestins; D004997:Ethinyl Estradiol; D009641:Norethynodrel; D010958:Plasminogen; D008656:Mestranol; D005341:Fibrinolysin; D008525:Medroxyprogesterone